High‐performance liquid chromatographic assay for etomidate in human plasma: Results of preliminary clinical studies using etomidate for hypnosis in total intravenous anesthesia

Michael J Avram*, Robert J. Fragen, Harry W. Linde

*Corresponding author for this work

Research output: Contribution to journalArticle

8 Scopus citations

Abstract

A sensitive and specific high‐performance liquid chromatographic assay was developed for the measurement of etomidate in human plasma following extraction of the drug and the internal standard. Using 0.5‐ml aliquots of plasma, the assay was linear in the concentration range of 20–2000 ng of etomidate/ml of plasma. This method was used to evaluate a preliminary clinical study of an etomidate infusion regimen for hypnosis in a total intravenous anesthesia protocol in 23 patients. The average duration of the infusion was 30 min, and awakening and alertness occurred 20 and 36 min after the termination of the infusion, respectively, at the respective plasma concentrations of 297 and 214 ng/ml. These results and this assay will be used to design and evaluate an improved etomidate infusion regimen.

Original languageEnglish (US)
Pages (from-to)1424-1426
Number of pages3
JournalJournal of Pharmaceutical Sciences
Volume72
Issue number12
DOIs
StatePublished - Jan 1 1983

Keywords

  • Etomidate—high‐performance liquid chromatography, human plasma, infusion, hypnosis in total intravenous anesthesia
  • High‐performance liquid chromatography—etomidate, human plasma, infusion, hypnosis in total intravenous anesthesia
  • Hypnotic agents—etomidate, infusion, hypnosis in total intravenous anesthesia, high‐performance liquid chromatography, human plasma

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint Dive into the research topics of 'High‐performance liquid chromatographic assay for etomidate in human plasma: Results of preliminary clinical studies using etomidate for hypnosis in total intravenous anesthesia'. Together they form a unique fingerprint.

  • Cite this